FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029043417> ?p ?o ?g. }

• W3029043417 endingPage "175883592091530" @default.
• W3029043417 startingPage "175883592091530" @default.
• W3029043417 abstract "Effective systemic treatment of non-clear cell renal carcinoma (nccRCC) is still an unmet clinical need, with few studies to support an evidence-based approach. To date, the only recommended standard first-line treatment is sunitinib. Pazopanib may also be used in nccRCC but its place in therapy is not clearly established. It has comparable efficacy and better tolerability than sunitinib in clear cell renal carcinoma. Our objective was to review the use of pazopanib in metastatic nccRCC.We conducted a systematic review according to PRISMA guidelines. Any type of study reporting the use of pazopanib in metastatic renal cell carcinoma including cases with non-clear cell histology was eligible.In all, 15 studies were included in our analysis, including a total of 318 nccRCC patients treated with pazopanib. Most studies were retrospective (n = 12); three were prospective trials. The specific outcomes of nccRCC patients were reported by four studies. Pazopanib alone as first-line treatment gave overall response rates ranging from 27% to 33%, disease control rates of 81-89%, median progression free survival of 8.1-16.5 months and median overall survival of 17.3-31.0 months. Grade 3-4 adverse events rates were 21-55%.The present review provides for the first time a systematic summary of evidence about the possible use of pazopanib as first-line treatment for nccRCC, with a favorable outcome despite the low strength of evidence. Pazopanib could be considered as a possible therapeutic option in this setting." @default.
• W3029043417 created "2020-06-05" @default.
• W3029043417 creator A5012176145 @default.
• W3029043417 creator A5013913173 @default.
• W3029043417 creator A5049304290 @default.
• W3029043417 creator A5050335373 @default.
• W3029043417 creator A5075851148 @default.
• W3029043417 date "2020-01-01" @default.
• W3029043417 modified "2023-10-18" @default.
• W3029043417 title "Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review" @default.
• W3029043417 cites W1965046203 @default.
• W3029043417 cites W1991408439 @default.
• W3029043417 cites W2007418983 @default.
• W3029043417 cites W2010991736 @default.
• W3029043417 cites W2021770899 @default.
• W3029043417 cites W2037716205 @default.
• W3029043417 cites W2063698832 @default.
• W3029043417 cites W2074416418 @default.
• W3029043417 cites W2111867681 @default.
• W3029043417 cites W2115966993 @default.
• W3029043417 cites W2116949558 @default.
• W3029043417 cites W2162225483 @default.
• W3029043417 cites W2162424705 @default.
• W3029043417 cites W2173523195 @default.
• W3029043417 cites W2222086386 @default.
• W3029043417 cites W2233483325 @default.
• W3029043417 cites W2288602056 @default.
• W3029043417 cites W2293115567 @default.
• W3029043417 cites W2463129937 @default.
• W3029043417 cites W2486639626 @default.
• W3029043417 cites W2507098989 @default.
• W3029043417 cites W2522519290 @default.
• W3029043417 cites W2566832984 @default.
• W3029043417 cites W2589774246 @default.
• W3029043417 cites W2593085122 @default.
• W3029043417 cites W2606055055 @default.
• W3029043417 cites W2616530946 @default.
• W3029043417 cites W2761005698 @default.
• W3029043417 cites W2785103248 @default.
• W3029043417 cites W2792937256 @default.
• W3029043417 cites W2885685834 @default.
• W3029043417 cites W2895828847 @default.
• W3029043417 cites W2904778411 @default.
• W3029043417 cites W2911812451 @default.
• W3029043417 cites W2913745075 @default.
• W3029043417 cites W2921784259 @default.
• W3029043417 cites W2921998768 @default.
• W3029043417 cites W2922202278 @default.
• W3029043417 cites W2945692214 @default.
• W3029043417 cites W3022903699 @default.
• W3029043417 doi "https://doi.org/10.1177/1758835920915303" @default.
• W3029043417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7278098" @default.
• W3029043417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32550862" @default.
• W3029043417 hasPublicationYear "2020" @default.
• W3029043417 type Work @default.
• W3029043417 sameAs 3029043417 @default.
• W3029043417 citedByCount "9" @default.
• W3029043417 countsByYear W30290434172020 @default.
• W3029043417 countsByYear W30290434172021 @default.
• W3029043417 countsByYear W30290434172022 @default.
• W3029043417 countsByYear W30290434172023 @default.
• W3029043417 crossrefType "journal-article" @default.
• W3029043417 hasAuthorship W3029043417A5012176145 @default.
• W3029043417 hasAuthorship W3029043417A5013913173 @default.
• W3029043417 hasAuthorship W3029043417A5049304290 @default.
• W3029043417 hasAuthorship W3029043417A5050335373 @default.
• W3029043417 hasAuthorship W3029043417A5075851148 @default.
• W3029043417 hasBestOaLocation W30290434171 @default.
• W3029043417 hasConcept C126322002 @default.
• W3029043417 hasConcept C143998085 @default.
• W3029043417 hasConcept C197934379 @default.
• W3029043417 hasConcept C2777472916 @default.
• W3029043417 hasConcept C2778375690 @default.
• W3029043417 hasConcept C2778439243 @default.
• W3029043417 hasConcept C2779490328 @default.
• W3029043417 hasConcept C535046627 @default.
• W3029043417 hasConcept C71924100 @default.
• W3029043417 hasConceptScore W3029043417C126322002 @default.
• W3029043417 hasConceptScore W3029043417C143998085 @default.
• W3029043417 hasConceptScore W3029043417C197934379 @default.
• W3029043417 hasConceptScore W3029043417C2777472916 @default.
• W3029043417 hasConceptScore W3029043417C2778375690 @default.
• W3029043417 hasConceptScore W3029043417C2778439243 @default.
• W3029043417 hasConceptScore W3029043417C2779490328 @default.
• W3029043417 hasConceptScore W3029043417C535046627 @default.
• W3029043417 hasConceptScore W3029043417C71924100 @default.
• W3029043417 hasLocation W30290434171 @default.
• W3029043417 hasLocation W30290434172 @default.
• W3029043417 hasLocation W30290434173 @default.
• W3029043417 hasLocation W30290434174 @default.
• W3029043417 hasOpenAccess W3029043417 @default.
• W3029043417 hasPrimaryLocation W30290434171 @default.
• W3029043417 hasRelatedWork W2154171266 @default.
• W3029043417 hasRelatedWork W2254527377 @default.
• W3029043417 hasRelatedWork W2557225468 @default.
• W3029043417 hasRelatedWork W2767323531 @default.
• W3029043417 hasRelatedWork W3087328364 @default.
• W3029043417 hasRelatedWork W3202900078 @default.

• next